<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>adjuvant therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/adjuvant-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 04 Oct 2026 18:30:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>adjuvant therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Immunotherapy Breakthroughs and Single-Cell Atlas Studies Reshape Liver Cancer Care in China</title>
		<link>https://bioengineer.org/immunotherapy-breakthroughs-and-single-cell-atlas-studies-reshape-liver-cancer-care-in-china/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 04 Oct 2026 18:30:16 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[adjuvant therapy]]></category>
		<category><![CDATA[drug resistance]]></category>
		<category><![CDATA[Hepatocellular Carcinoma]]></category>
		<category><![CDATA[Immune checkpoint inhibitors]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[liver cancer]]></category>
		<category><![CDATA[neoadjuvant therapy]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[single-cell sequencing]]></category>
		<category><![CDATA[Spatial transcriptomics]]></category>
		<category><![CDATA[transarterial chemoembolization]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=401161</guid>

					<description><![CDATA[A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and understanding of hepatocellular carcinoma.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">401161</post-id>	</item>
	</channel>
</rss>
